Stockscreener 앱 받기
3.16
0.94%
-0.03
시간 외 거래:
3.15
-0.01
-0.32%
전일 마감가:
$3.19
열려 있는:
$3.24
하루 거래량:
195.45K
Relative Volume:
1.65
시가총액:
$97.56M
수익:
-
순이익/손실:
$-10.74M
주가수익비율:
-9.2941
EPS:
-0.34
순현금흐름:
$-6.53M
1주 성능:
+8.97%
1개월 성능:
+33.90%
6개월 성능:
+4.64%
1년 성능:
-29.15%
1일 변동 폭
$2.97
$3.25
1주일 범위
$2.65
$3.25
52주 변동 폭
$2.07
$4.6682
Anixa Biosciences Inc Stock (ANIX) Company Profile
명칭
Anixa Biosciences Inc
전화
408-708-9808
주소
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE
ANIX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ANIX
Anixa Biosciences Inc
|
3.16 | 97.56M | 0 | -10.74M | -6.53M | -0.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.32 | 122.13B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
710.00 | 78.30B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
646.64 | 39.73B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
276.19 | 35.50B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.61 | 28.47B | 3.30B | -501.07M | 1.03B | -2.1146 |
Anixa Biosciences Inc Stock (ANIX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-12-23 | 개시 | Chardan Capital Markets | Buy |
| 2021-04-12 | 개시 | H.C. Wainwright | Buy |
Anixa Biosciences Inc 주식(ANIX)의 최신 뉴스
Anixa Biosciences Inc (ANIX) Stock: A Closer Look at the Market Potential - The News Heater
Contrasting Eterna Therapeutics (NASDAQ:ERNA) and Anixa Biosciences (NASDAQ:ANIX) - Defense World
Anixa Biosciences' Chairman & CEO Dr. Amit Kumar Featured on CW39's H-Town Live to Discuss the Future of Breast Cancer Prevention - PR Newswire
Insider Buying: Anixa Biosciences, Inc. (NASDAQ:ANIX) Director Purchases 5,000 Shares of Stock - MarketBeat
Anixa biosciences director Arnold Baskies buys $14,100 in stock - MSN
Insider Buying: Arnold Baskies Acquires Additional Shares of Ani - GuruFocus.com
Anixa biosciences director Arnold Baskies buys $14,100 in stock By Investing.com - Investing.com UK
Anixa Biosciences director Titterton buys $8,820 in common stock - MSN
Anixa Biosciences director Titterton buys $8,820 in common stock By Investing.com - Investing.com Australia
Anixa Biosciences’ (ANIX) Buy Rating Reiterated at D. Boral Capital - Defense World
Anixa Biosciences reports progress in cancer vaccine trials - MSN
Anixa Biosciences director Lewis Titterton buys $6,020 worth of stock - Investing.com
Anixa Biosciences director Lewis Titterton buys $6,020 worth of stock By Investing.com - Investing.com Australia
Anixa Biosciences (ANIX) Stock Price, News & Analysis - MarketBeat
Anixa Biosciences director Lewis H. Titterton Jr. buys $15,540 in stock - MSN
Insider Buying: Titterton Lewis H jr Acquires Additional Shares of Anixa Biosciences Inc (ANIX) - GuruFocus.com
Anixa Biosciences, Inc. (NASDAQ:ANIX) Director Purchases $15,540.00 in Stock - MarketBeat
D. Boral Capital Reiterates Buy Rating for Anixa Biosciences (NASDAQ:ANIX) - MarketBeat
AnixaCharting The Path To A Healthier Future - RTTNews
Anixa Biosciences CEO Provides Letter to Shareholders - The Malaysian Reserve
Anixa Biosciences (ANIX) Projected to Post Earnings on Tuesday - Defense World
Anixa Biosciences, Inc. (NASDAQ:ANIX) Director Buys $25,700.00 in Stock - MarketBeat
Insider Buying: Titterton Lewis H Jr Acquires Additional Shares of Anixa Biosciences Inc - GuruFocus.com
Anixa biosciences director Lewis Titterton buys shares worth $25,700 - MSN
Anixa biosciences director Lewis Titterton buys shares worth $25,700 By Investing.com - Investing.com Canada
Anixa Biosciences Leads 3 Promising Penny Stocks On US Exchanges - Simply Wall St
Anixa Biosciences president Michael Catelani buys $19,971 in shares By Investing.com - Investing.com Australia
CEO Amit Kumar Increases Stake in Anixa Biosciences Inc - GuruFocus.com
Anixa Biosciences CEO Amit Kumar buys $95,890 in common stock By Investing.com - Investing.com Canada
Anixa Biosciences (ANIX) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Insider Buying: Michael Catelani Increases Stake in Anixa Biosci - GuruFocus.com
Insider Buying: Anixa Biosciences, Inc. (NASDAQ:ANIX) CEO Buys 43,000 Shares of Stock - MarketBeat
Anixa Biosciences, Inc. (NASDAQ:ANIX) CFO Michael Catelani Acquires 9,289 Shares - MarketBeat
Anixa Biosciences president Michael Catelani buys $19,971 in shares - Investing.com India
The ‘decade for cancer’: Anixa Biosciences CEO Amit Kumar on cancer vax future - MM+M Online
Anixa Biosciences Inc (ANIX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Anixa Biosciences Inc 주식 (ANIX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Titterton Lewis H jr | Director |
Jan 23 '25 |
Buy |
2.91 |
2,000 |
5,820 |
932,334 |
| Titterton Lewis H jr | Director |
Jan 24 '25 |
Buy |
3.00 |
1,000 |
3,000 |
933,334 |
| Titterton Lewis H jr | Director |
Jan 22 '25 |
Buy |
3.01 |
2,000 |
6,020 |
930,334 |
| Titterton Lewis H jr | Director |
Jan 21 '25 |
Buy |
2.59 |
6,000 |
15,540 |
928,334 |
| Titterton Lewis H jr | Director |
Jan 17 '25 |
Buy |
2.57 |
10,000 |
25,700 |
922,334 |
| KUMAR AMIT | Chief Executive Officer |
Jan 15 '25 |
Buy |
2.23 |
43,000 |
95,890 |
559,925 |
| Catelani Michael | President, COO, & CFO |
Jan 15 '25 |
Buy |
2.15 |
9,289 |
19,971 |
44,500 |
| Titterton Lewis H jr | Director |
Oct 22 '24 |
Option Exercise |
2.58 |
16,000 |
41,200 |
912,334 |
| Titterton Lewis H jr | Director |
Jul 30 '24 |
Buy |
3.06 |
21,646 |
66,237 |
890,754 |
| Titterton Lewis H jr | Director |
Jul 31 '24 |
Buy |
3.23 |
5,580 |
18,023 |
896,334 |
1.09%
자본화:
|
볼륨(24시간):